Gimv NV
Closed
SectorFinance
44.35 -0.45
Overview
Share price change
24h
Min
44.35
Max
44.55
Income | 127M |
|---|---|
Sales | 65M |
P/E Sector Avg | 8.034 41.721 |
EPS | 3.4 |
Dividend yield | 5.59 |
Profit margin | 195.239 |
Employees | 95 |
EBITDA | 128M |
Dividend yield Sector Avg | 5.59% 4.65% |
|---|---|
Next Earnings | 11 Jun 2026 |
Market Cap | 1.7B |
|---|---|
Previous open | 44.8 |
Previous close | 44.35 |
News Sentiment
By Acuity
50%
50%
174 / 439 Finance
Gimv NV Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Gimv NV Forecast
Sentiment
By Acuity
174 / 439 Finance
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Above average
Financials
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Gimv NV
Gimv NV is a private equity and venture capital firm specializing in direct and fund of funds investments. For direct investments, the firm specializes in buyouts, growth capital, middle market, debt, shareholder loans, seed, startups, early to mid-stage, late venture, public to private transactions, small and medium sized enterprises, later stage, mature, replacement capital, bridge financing, and recapitalization. Within fund of funds, it seeks to invest in venture capital and private equity funds. It seeks to invest in high performance growth companies that respond to that can speed up their internal growth through acquisitions. The firm typically invests in consumer, connected consumer, fintech; health and care; smart industries; and sustainable cities. Within consumer, it seeks to provide growth capital to emerging leaders. Within health and care platform, the firm seeks to invest in companies that can grow either organically or through a buy and build strategy. Within consumer, it focuses on consumer goods, food and beverage, healthy food, sport, convenience food, personal luxury, career, home & deco, baby & kids, pet products, retail, consumer services, media and content, travel and leisure, education, digital economy and online sectors. Within health and care sector, it focuses on life sciences, medtech, and health and care services. The firm focuses on biotech/biopharma comprising drugs, platform technologies, vaccines and diagnostic tests, preclinical, early clinical, and late clinical, medtech such as medical devices, consumables, IT and small equipment, and health and care services-based companies. It also seeks to be an active shareholder, preferably lead or co-lead in its investments. Within smart industries, it focuses on equipment, services and tools for resource efficient development and production, automotive and aerospace, both optimizing of the existing and development of new means of transport, software and services harnessing the flexibility of the cloud, smart data management and advanced c
